RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.
Condition: Breast Cancer Intervention: Sponsor: Pfizer Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials